BioStem Technologies (BSEM) stock gains as Medicare sets national pricing for the company's wound care product Vendaje AC.

Medicare reimbursement issues expected for certain of Organogenesis' skin substitute projects disrupting revenues in 2025.

Around 30 GP surgeries in Buckinghamshire have said they will stop delivering unfunded post-operative wound care. Many of the practices served notice over summer that they would no longer provide the ...

Ontario long-term care facilities are left to navigate the balance between protecting the concerns of residents and their loved ones with respecting the rights and privacy of staff ...

Ward said traditionally, biologic wound care products – as opposed to synthetic ... beyond the US as part of its strategy for long-term growth, including into regions like Taiwan, Switzerland ...

WINNIPEG, Manitoba, Oct. 17, 2024 (GLOBE NEWSWIRE) -- (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it ...

Common Stock Will Begin Trading on a Split-adjusted Basis on8, 2024. EDEN PRAIRIE, Minn., Oct. 16, 2024 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (the "Company” or "SA ...

Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, is proud to announce that its RENASYS EDGE Negative ...

Based in Fort Worth, Texas, (“Sanara” or the “Company”) (NASDAQ: SMTI), a medical technology company focused on improving ...

Sports Medicine & ENT and Advanced Wound Management. Founded in Hull, UK, in 1856, we now operate in more than 100 countries, and generated annual sales of $5.5 billion in 2023. Smith+Nephew is a ...

WASHINGTON — If he wins next month’s election, Donald Trump would be the oldest person in U.S. history to be elected ...